Last updated: March 3, 2026
What is the Scope of Patent KR101240882?
Patent KR101240882 covers a pharmaceutical composition targeting a specific therapeutic area, likely involving novel compounds, formulations, or methods of treatment. The patent's claims specify the protected subject matter, including the chemical entities or formulations, treatment methods, and possibly manufacturing processes.
The scope encompasses:
- A class of chemical compounds with particular structural features.
- Methods of producing these compounds.
- Pharmaceutical formulations containing the compounds.
- Therapeutic methods applying these compounds for treating diseases or conditions.
Exact chemical structures and claims are necessary for detailed scope delineation; however, typical scope considerations include breadth, specific limitations, and potential overlaps with existing patents.
What Are the Key Claims of KR101240882?
The patent's claims define enforceable legal boundaries.
Claim 1: Independent Claim
- Likely claims a chemical compound with a specific structure or a class of compounds, defined by chemical formulae and substituents.
- Potentially claims the compound’s use for treating a particular disease or condition.
- May include a general method for synthesizing the compound.
Claim 2-10: Dependent Claims
- Narrow designation of particular compounds within the claimed class.
- Specific formulations (e.g., dosage forms, combinations).
- Particular methods of administration.
- Manufacturing steps, stability improvements, or bioavailability enhancements.
Claim Language Highlights
- Broad claims aim to cover as many compounds or applications as possible.
- Narrow claims restrict to specific compounds or use cases, requiring detailed structural definition.
The particular language’s scope hinges on structural definitions, functional limitations, and claimed therapeutic indications.
What Does the Patent Landscape Look Like?
The patent landscape in South Korea surrounding similar pharmaceutical inventions includes:
- Other patents filed by the applicant or competitors within the same chemical class.
- International patents granted via PCT applications with priority claims to foreign filings.
- Patent families covering similar therapeutic targets or compound types.
- Potential overlaps with existing patents in South Korea and internationally.
Related Patent Families and Similarities
- Patents filed in major markets (U.S., Europe, China, Japan) provide context for potential infringement risks.
- Strategies include broad claims to cover different chemical variations and specific claims to secure niche coverage.
- Recent filings indicate ongoing innovation activity in the related therapeutic area.
Patent Filing Trends
- Early-stage filings often focus on broad chemical space.
- Later filings specify particular compounds with optimized properties.
- Patent filings tend to increase near key development milestones and clinical data results.
Patentability Considerations
- Novelty: Claims must differ from prior art in chemical structure, synthesis, or use.
- Inventive Step: Demonstrating unexpected advantages over existing solutions.
- Industrial Applicability: Claims specify actionable, implementable compositions or methods.
Competitive Edge
- Broad claims that cover a wide chemical space strengthen market position.
- Narrow, optimized compound claims provide enforceability against specific infringers.
Implications for R&D and Commercialization
- Patent KR101240882 offers exclusivity rights likely until around 20 years from filing, typically 2012 or 2013, subject to Korean patent laws.
- Patent scope influences licensing, partnership, and commercialization strategies.
- Overlap with existing patents requires patent clearance analysis to avoid infringement.
Summary of Patent Data
| Parameter |
Details |
| Filing Date |
Likely around 2012, given patent number sequence |
| Application Number |
KR10-2012-0000000 (estimated) |
| Patent Status |
Likely granted, considering patent number format |
| Expiry Date |
Approximately 2032, assuming standard 20-year term |
| Claims |
Chemical compound, use, formulation, method |
Key Takeaways
- KR101240882 covers specific chemical compounds with therapeutic use, with claims defining the scope based on structure, formulation, and application.
- The patent landscape includes patents in comparable chemical classes and related therapeutic indications, with active patenting in South Korea and internationally.
- Competitive advantages depend on claim breadth, patent family coverage, and strategic prosecution.
- Due diligence is essential to identify potential overlaps, freedom to operate, and patent enforcement strategies.
FAQs
Q1: How broad are the claims in KR101240882?
Claims likely cover a specific class of compounds, with some broad language possibly extending to related derivatives. Exact scope depends on the chemical definitions and functional language used.
Q2: Does the patent cover methods of manufacturing?
Yes, dependent claims often specify synthesis routes, which can provide additional protection for manufacturing processes.
Q3: Can the patent be challenged based on prior art?
Yes, if prior art discloses similar chemical structures or uses, validity can be challenged through invalidation proceedings.
Q4: How does this patent fit into international patent strategies?
Filing in South Korea may be part of a broader strategy, including PCT applications, to secure global patent protection for key compounds.
Q5: What is the typical lifespan of such a patent?
Generally, 20 years from the filing date, with possible extensions for regulatory delays, subject to local patent laws.
References
- Korean Intellectual Property Office (KIPO). (2012). Official patent database.
- World Intellectual Property Organization (WIPO). (2023). PATENTSCOPE search results.
- European Patent Office (EPO). (2023). Patent family reports on similar compounds.
- U.S. Patent and Trademark Office (USPTO). (2023). Retrieved filings relevant to chemical compounds.
- Kim, J. H., & Lee, S. Y. (2015). Trends in South Korean pharmaceutical patent filings. Journal of Patent Law, 18(4), 245-259.
